<DOC>
	<DOCNO>NCT02796781</DOCNO>
	<brief_summary>Interstitial lung disease ( ILD ) group diseases affect lung interstitium . The lung scar occurs ILD often irreversible mitigate therapy available far . This study intend carry open , single-armed , phase I/II clinical trial investigate whether lung stem cell regenerate damage lung tissue . During treatment , lung stem cell isolated patient ' bronchus expand vitro . After careful characterization , culture cell inject directly lesion fiberoptic bronchoscopy . The safety efficacy treatment monitor measure key clinical indicator .</brief_summary>
	<brief_title>Autologous Lung Stem Cell Transplantation Patients With Interstitial Lung Diseases</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>Diagnosed interstitial lung disease Clinically stable Written inform consent sign Allergic cell therapy ; Patients serious significant pulmonary infection need antiinfection treatment ; Patients take amiodarone may cause pulmonary fibrosis past 3 month ; Patients malignant tumor past 5 year ; Participated clinical trial past 3 month ; Patients serious heart disease ( NYHA class ⅢⅣ ) Pregnant lactate woman ; The investigator assess inappropriate participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>